promotion image of download ymail app
Promoted
Dochi 發問時間: 社會與文化語言 · 1 0 年前

徵求英文高手幫忙翻譯(關於生物)謝謝

22.7 HOW SHOULD CLINICIANS RESPOND TO PREDICTION RESULTS?

If and when reliable predictive assays are developed,their use will depend on available alternative treatments. The following are some examples of possible courses of action. Patients with very hypoxic tumours could be assigned to treatments that include hypoxia-modifying or hypoxia-exploiting agents, such as ARCON or tirapazamine (see Section 16.8). Tumours with fast proliferation rates will be candidates for accelerated fractionation, or radiotherapy given together with drugs designed to combat proliferation,

such as EGFR inhibitors. Patients with radioresistant tumours may benefit from switching to an alternative therapeutic modality such as surgery or chemotherapy, combined chemoradiotherapy or the radiation dose to the tumour could be increased using some form of conformal radiotherapy. If reliable predictive information is available on normal-tissue sensitivity, possible strategies would be to reduce the radiation

dose for radiosensitive individuals, to offer a radioprotective agent (only if the agent does not also protect tumours), or to use a post-radiotherapy approach such as anti-TGF-P antibodies or antisense oligonucleotides.

已更新項目:

不要用翻譯軟體翻的

2 個解答

評分
  • 1 0 年前
    最佳解答

    22.7 臨床工作者怎麼應該反應預言結果? 如果和當可靠的有預測性的分析用試樣被開發, 他們的用途將取決於可利用的供選擇的治療。下列是可能的計劃一些例子。患者以非常缺氧腫瘤能被分配到包括低氧症修改或低氧症剝削代理的治療, 譬如ARCON 或tirapazamine (參見部分16.8) 。腫瘤以快速的擴散速度將是候選人為加速的分餾, 或放射療法被給與藥物一起被設計與擴散交戰, 譬如EGFR 抗化劑。患者以radioresistant 腫瘤也許受益於交換對一種供選擇的治療形式譬如手術或化療, 聯合的chemoradiotherapy 或輻射藥量對腫瘤能被增加使用某種保形放射療法的形式。如果可靠的有預測性的資訊是可利用的在正常組織敏感性, 可能的戰略會是減少輻射藥量為對射線敏感的個體, 提供一個radioprotective 代理(只如果代理並且不保護腫瘤), 或使用崗位放射療法方法譬如anti-TGF-P 抗體或antisense oligonucleotides 。

    • Commenter avatar登入以對解答發表意見
  • 1 0 年前

    不好意思唷~是想頃人幫忙翻譯這個章節

    • Commenter avatar登入以對解答發表意見
還有問題?馬上發問,尋求解答。